<DOC>
	<DOCNO>NCT00975611</DOCNO>
	<brief_summary>The purpose study show amantadine might help reduce side effect medication prescribe treat schizophrenia schizoaffective disorder . High level hormone prolactin , hyperprolactinemia , one side effect might develop patient treat paliperidone ER risperidone Consta . High level prolactin might stimulate breast development , might decrease sexual desire ( libido ) . The goal study demonstrate amantadine lower prolactin level , decrease side effect , improve psychiatric symptom .</brief_summary>
	<brief_title>Study Amantadine Risperidone Consta Paliperidone Treated Patients Decrease Prolactin Elevation</brief_title>
	<detailed_description>Trial Description : A double-blind , placebo-controlled , prospective , randomized trial evaluate effect two dos amantadine placebo management antipsychotic-induced hyperprolactinemia psychiatric status patient schizophrenia schizoaffective disorder clinically stable paliperidone ER risperidone Consta . Placebo amantadine 100 mg 200 mg BID administer participant 4 consecutive week adjunctive therapy 72 schizophrenia subject treat paliperidone risperidone Consta examine amantadine effect fast AM serum prolactin level . Participants follow suspension amantadine placebo additional 4 week safety purpose . The goal study prospectively demonstrate amantadine lower prolactin level , evaluate impact amantadine psychiatric symptom , prolactin-related side effect patient treat paliperidone ER risperidone Consta .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Amantadine</mesh_term>
	<mesh_term>Paliperidone Palmitate</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>Male female Age 1865 year Diagnosis schizophrenia , schizoaffective disorder , subtype schizophreniform disorder Well establish compliance outpatient medication include paliperidone ER risperidone Consta 3 month Current substance alcohol abuse Significant medical illness Women pregnant , breastfeeding , unwilling unable use effective form birth control entire study Subjects treat one antipsychotic drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>schizoaffective disorder</keyword>
	<keyword>paliperidone ER</keyword>
	<keyword>risperidone Consta</keyword>
	<keyword>prolactin</keyword>
	<keyword>hyperprolactinemia</keyword>
</DOC>